{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:22:49Z","timestamp":1790716969129,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2020YFA0113100"],"award-info":[{"award-number":["2020YFA0113100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Science and Technology Innovation Action Plan of the Science and Technology Commission of Shanghai Municipality","award":["20JC1412000"],"award-info":[{"award-number":["20JC1412000"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04187-8","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T12:08:40Z","timestamp":1738930120000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy of human umbilical cord mesenchymal stem cell in the treatment of neuromyelitis optica spectrum disorders: an animal study"],"prefix":"10.1186","volume":"16","author":[{"given":"Chunran","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuzhong","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7322-6842","authenticated-orcid":false,"given":"Yangtai","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"issue":"1","key":"4187_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41572-020-0214-9","volume":"6","author":"S Jarius","year":"2020","unstructured":"Jarius S, Paul F, Weinshenker BG, Levy M, Kim HJ, Wildemann B. Neuromyelitis optica. Nat Rev Dis Primers. 2020;6(1):85. https:\/\/doi.org\/10.1038\/s41572-020-0214-9.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"4187_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","volume":"18","author":"E Carnero Contentti","year":"2021","unstructured":"Carnero Contentti E, Correale J. Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies. J Neuroinflamm. 2021;18(1):208. https:\/\/doi.org\/10.1186\/s12974-021-02249-1.","journal-title":"J Neuroinflamm"},{"issue":"2","key":"4187_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1212\/wnl.0000000000011153","volume":"96","author":"V Papp","year":"2021","unstructured":"Papp V, Magyari M, Aktas O, Berger T, Broadley SA, Cabre P, et al. Worldwide incidence and prevalence of neuromyelitis optica: a systematic review. Neurology. 2021;96(2):59\u201377. https:\/\/doi.org\/10.1212\/wnl.0000000000011153.","journal-title":"Neurology"},{"issue":"9","key":"4187_CR4","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/s1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6(9):805\u201315. https:\/\/doi.org\/10.1016\/s1474-4422(07)70216-8.","journal-title":"Lancet Neurol"},{"issue":"1","key":"4187_CR5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12974-018-1333-z","volume":"15","author":"T Duan","year":"2018","unstructured":"Duan T, Smith AJ, Verkman AS. Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica. J Neuroinflamm. 2018;15(1):294. https:\/\/doi.org\/10.1186\/s12974-018-1333-z.","journal-title":"J Neuroinflamm"},{"issue":"1","key":"4187_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00401-017-1734-6","volume":"134","author":"L Tradtrantip","year":"2017","unstructured":"Tradtrantip L, Yao X, Su T, Smith AJ, Verkman AS. Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica. Acta Neuropathol. 2017;134(1):35\u201344. https:\/\/doi.org\/10.1007\/s00401-017-1734-6.","journal-title":"Acta Neuropathol"},{"issue":"12","key":"4187_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41582-021-00568-8","volume":"17","author":"SJ Pittock","year":"2021","unstructured":"Pittock SJ, Zekeridou A, Weinshenker BG. Hope for patients with neuromyelitis optica spectrum disorders\u2014From mechanisms to trials. Nat Rev Neurol. 2021;17(12):759\u201373. https:\/\/doi.org\/10.1038\/s41582-021-00568-8.","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"4187_CR8","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.3390\/ijms23084154","volume":"23","author":"K Giglhuber","year":"2022","unstructured":"Giglhuber K, Berthele A. Adverse events in NMOSD therapy. Int J Mol Sci. 2022;23(8):4154. https:\/\/doi.org\/10.3390\/ijms23084154.","journal-title":"Int J Mol Sci"},{"key":"4187_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/978-1-4939-7799-4_13","volume":"1773","author":"J Li","year":"2018","unstructured":"Li J, Curley JL, Floyd ZE, Wu X, Halvorsen YDC, Gimble JM. Isolation of human adipose-derived stem cells from lipoaspirates. Methods Mol Biol. 2018;1773:155\u201365. https:\/\/doi.org\/10.1007\/978-1-4939-7799-4_13.","journal-title":"Methods Mol Biol"},{"issue":"122","key":"4187_CR10","doi-asserted-by":"publisher","first-page":"55224","DOI":"10.3791\/55224","volume":"3","author":"N Beeravolu","year":"2017","unstructured":"Beeravolu N, McKee C, Alamri A, Mikhael S, Brown C, Perez-Cruet M, et al. Isolation and characterization of mesenchymal stromal cells from human umbilical cord and fetal placenta. J Vis Exp. 2017;3(122):55224. https:\/\/doi.org\/10.3791\/55224.","journal-title":"J Vis Exp"},{"issue":"3","key":"4187_CR11","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3390\/ijms21030708","volume":"21","author":"DT Chu","year":"2020","unstructured":"Chu DT, Phuong TNT, Tien NLB, Tran DK, Thanh VV, Quang TL, et al. An update on the progress of isolation, culture, storage, and clinical application of human bone marrow mesenchymal stem\/stromal cells. Int J Mol Sci. 2020;21(3):708. https:\/\/doi.org\/10.3390\/ijms21030708.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4187_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000704","volume":"9","author":"DL Kamen","year":"2022","unstructured":"Kamen DL, Wallace C, Li Z, Wyatt M, Paulos C, Wei C, et al. Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE. Lupus Sci Med. 2022;9(1): e000704. https:\/\/doi.org\/10.1136\/lupus-2022-000704.","journal-title":"Lupus Sci Med"},{"issue":"1","key":"4187_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13287-022-02941-w","volume":"13","author":"M Izadi","year":"2022","unstructured":"Izadi M, Sadr Hashemi Nejad A, Moazenchi M, Masoumi S, Rabbani A, Kompani F, et al. Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I\/II randomized placebo-controlled clinical trial. Stem Cell Res Ther. 2022;13(1):264. https:\/\/doi.org\/10.1186\/s13287-022-02941-w.","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"4187_CR14","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1093\/brain\/awaa333","volume":"143","author":"P Petrou","year":"2020","unstructured":"Petrou P, Kassis I, Levin N, Paul F, Backner Y, Benoliel T, et al. Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis. Brain. 2020;143(12):3574\u201388. https:\/\/doi.org\/10.1093\/brain\/awaa333.","journal-title":"Brain"},{"issue":"5","key":"4187_CR15","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3727\/096368910x536473","volume":"20","author":"T Deuse","year":"2011","unstructured":"Deuse T, Stubbendorff M, Tang-Quan K, Phillips N, Kay MA, Eiermann T, et al. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant. 2011;20(5):655\u201367. https:\/\/doi.org\/10.3727\/096368910x536473.","journal-title":"Cell Transplant"},{"issue":"3","key":"4187_CR16","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3892\/ijmm.2014.1821","volume":"34","author":"X Li","year":"2014","unstructured":"Li X, Bai J, Ji X, Li R, Xuan Y, Wang Y. Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation. Int J Mol Med. 2014;34(3):695\u2013704. https:\/\/doi.org\/10.3892\/ijmm.2014.1821.","journal-title":"Int J Mol Med"},{"key":"4187_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neulet.2013.03.018","volume":"541","author":"SF Zhu","year":"2013","unstructured":"Zhu SF, Zhong ZN, Fu XF, Peng DX, Lu GH, Li WH, et al. Comparison of cell proliferation, apoptosis, cellular morphology and ultrastructure between human umbilical cord and placenta-derived mesenchymal stem cells. Neurosci Lett. 2013;541:77\u201382. https:\/\/doi.org\/10.1016\/j.neulet.2013.03.018.","journal-title":"Neurosci Lett"},{"issue":"8","key":"4187_CR18","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/cns.12559","volume":"22","author":"Y Fu","year":"2016","unstructured":"Fu Y, Yan Y, Qi Y, Yang L, Li T, Zhang N, et al. Impact of autologous mesenchymal stem cell infusion on neuromyelitis optica spectrum disorder: a pilot, 2-year observational study. CNS Neurosci Ther. 2016;22(8):677\u201385. https:\/\/doi.org\/10.1111\/cns.12559.","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"4187_CR19","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2174\/156720212803530708","volume":"9","author":"Z Lu","year":"2012","unstructured":"Lu Z, Ye D, Qian L, Zhu L, Wang C, Guan D, et al. Human umbilical cord mesenchymal stem cell therapy on neuromyelitis optica. Curr Neurovasc Res. 2012;9(4):250\u20135. https:\/\/doi.org\/10.2174\/156720212803530708.","journal-title":"Curr Neurovasc Res"},{"issue":"1\u20132","key":"4187_CR20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jns.2013.05.035","volume":"331","author":"H Haruki","year":"2013","unstructured":"Haruki H, Sano Y, Shimizu F, Omoto M, Tasaki A, Oishi M, et al. NMO sera down-regulate AQP4 in human astrocyte and induce cytotoxicity independent of complement. J Neurol Sci. 2013;331(1\u20132):136\u201344. https:\/\/doi.org\/10.1016\/j.jns.2013.05.035.","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"4187_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jneuroim.2009.07.014","volume":"215","author":"L Sabater","year":"2009","unstructured":"Sabater L, Giralt A, Boronat A, Hankiewicz K, Blanco Y, Llufriu S, et al. Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: an in vitro study. J Neuroimmunol. 2009;215(1\u20132):31\u20135. https:\/\/doi.org\/10.1016\/j.jneuroim.2009.07.014.","journal-title":"J Neuroimmunol"},{"key":"4187_CR22","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.2147\/dddt.S225613","volume":"13","author":"L Wang","year":"2019","unstructured":"Wang L, Huang S, Li S, Li M, Shi J, Bai W, et al. Efficacy and safety of umbilical cord mesenchymal stem cell therapy for rheumatoid arthritis patients: a prospective phase I\/II study. Drug Des Devel Ther. 2019;13:4331\u201340. https:\/\/doi.org\/10.2147\/dddt.S225613.","journal-title":"Drug Des Devel Ther"},{"issue":"4","key":"4187_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1055\/a-1995-6365","volume":"73","author":"R Ahmadifard","year":"2023","unstructured":"Ahmadifard R, Jafarzadeh A, Mahmoodi M, Nemati M, Rahmani M, Khorramdelazad H, et al. Interferon-\u03b3-treated mesenchymal stem cells modulate the T cell-related chemokines and chemokine receptors in an animal model of experimental autoimmune encephalomyelitis. Drug Res. 2023;73(4):213\u201323. https:\/\/doi.org\/10.1055\/a-1995-6365.","journal-title":"Drug Res"},{"issue":"2","key":"4187_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1999","volume":"11","author":"JM Zhang","year":"2021","unstructured":"Zhang JM, Wang H, Fan YY, Yang FH. Effect of mesenchymal stem cells transplantation on the changes of oligodendrocyte lineage in rat brain with experimental autoimmune encephalomyelitis. Brain Behav. 2021;11(2): e01999. https:\/\/doi.org\/10.1002\/brb3.1999.","journal-title":"Brain Behav"},{"issue":"1","key":"4187_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41536-024-00349-z","volume":"9","author":"H Xu","year":"2024","unstructured":"Xu H, Jiang W, Li X, Jiang J, Afridi SK, Deng L, et al. hUC-MSCs-derived MFGE8 ameliorates locomotor dysfunction via inhibition of ITGB3\/NF-\u03baB signaling in an NMO mouse model. NPJ Regen Med. 2024;9(1):4. https:\/\/doi.org\/10.1038\/s41536-024-00349-z.","journal-title":"NPJ Regen Med"},{"issue":"1","key":"4187_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13287-018-0979-x","volume":"9","author":"J Fan","year":"2018","unstructured":"Fan J, Tang X, Wang Q, Zhang Z, Wu S, Li W, et al. Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9. Stem Cell Res Ther. 2018;9(1):237. https:\/\/doi.org\/10.1186\/s13287-018-0979-x.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"4187_CR27","doi-asserted-by":"publisher","first-page":"711","DOI":"10.18502\/ijaai.v20i6.8022","volume":"20","author":"P Lotfinejad","year":"2021","unstructured":"Lotfinejad P, Shamsasenjan K, Baradaran B, Safarzadeh E, Kazemi T, Movassaghpour AA. Immunomodulatory effect of human umbilical cord blood-derived mesenchymal stem cells on activated T-lymphocyte. Iran J Allergy Asthma Immunol. 2021;20(6):711\u201320. https:\/\/doi.org\/10.18502\/ijaai.v20i6.8022.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"4187_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.835345","volume":"13","author":"X Ling","year":"2022","unstructured":"Ling X, Wang T, Han C, Wang P, Liu X, Zheng C, et al. IFN-\u03b3-primed hUCMSCs significantly reduced inflammation via the Foxp3\/ROR-\u03b3t\/STAT3 signaling pathway in an animal model of multiple sclerosis. Front Immunol. 2022;13: 835345. https:\/\/doi.org\/10.3389\/fimmu.2022.835345.","journal-title":"Front Immunol"},{"issue":"7","key":"4187_CR29","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1007\/s11064-020-03009-y","volume":"45","author":"X Zhou","year":"2020","unstructured":"Zhou X, Liu X, Liu L, Han C, Xie Z, Liu X, et al. Transplantation of IFN-\u03b3 primed hUCMSCs significantly improved outcomes of experimental autoimmune encephalomyelitis in a mouse model. Neurochem Res. 2020;45(7):1510\u20137. https:\/\/doi.org\/10.1007\/s11064-020-03009-y.","journal-title":"Neurochem Res"},{"issue":"1","key":"4187_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4049\/jimmunol.1302164","volume":"192","author":"C Xu","year":"2014","unstructured":"Xu C, Yu P, Han X, Du L, Gan J, Wang Y, et al. TGF-\u03b2 promotes immune responses in the presence of mesenchymal stem cells. J Immunol. 2014;192(1):103\u20139. https:\/\/doi.org\/10.4049\/jimmunol.1302164.","journal-title":"J Immunol"},{"issue":"1","key":"4187_CR31","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13287-020-01700-z","volume":"11","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wang X, Lu X, Ma Y, Xin X, Xu X, et al. Tetramethylpyrazine enhanced the therapeutic effects of human umbilical cord mesenchymal stem cells in experimental autoimmune encephalomyelitis mice through Nrf2\/HO-1 signaling pathway. Stem Cell Res Ther. 2020;11(1):186. https:\/\/doi.org\/10.1186\/s13287-020-01700-z.","journal-title":"Stem Cell Res Ther"},{"key":"4187_CR32","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16311","volume":"11","author":"C Xue","year":"2023","unstructured":"Xue C, Ma X, Guan X, Feng H, Zheng M, Yang X. Small extracellular vesicles derived from umbilical cord mesenchymal stem cells repair blood-spinal cord barrier disruption after spinal cord injury through down-regulation of Endothelin-1 in rats. PeerJ. 2023;11: e16311. https:\/\/doi.org\/10.7717\/peerj.16311.","journal-title":"PeerJ"},{"key":"4187_CR33","doi-asserted-by":"publisher","first-page":"8667045","DOI":"10.1155\/2023\/8667045","volume":"2023","author":"J Yang","year":"2023","unstructured":"Yang J, Li H, Ran M, Yang S, Ma K, Zhang C, et al. Transplantation of umbilical cord-derived mesenchymal stem cells attenuates surgical wound-induced blood\u2013brain barrier dysfunction in mice. Stem Cells Int. 2023;2023:8667045. https:\/\/doi.org\/10.1155\/2023\/8667045.","journal-title":"Stem Cells Int"},{"issue":"5","key":"4187_CR34","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/wnr.0b013e32832776f4","volume":"20","author":"M Kinoshita","year":"2009","unstructured":"Kinoshita M, Nakatsuji Y, Moriya M, Okuno T, Kumanogoh A, Nakano M, et al. Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum. NeuroReport. 2009;20(5):508\u201312. https:\/\/doi.org\/10.1097\/wnr.0b013e32832776f4.","journal-title":"NeuroReport"},{"issue":"3","key":"4187_CR35","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/glia.23919","volume":"69","author":"JEG Vaes","year":"2021","unstructured":"Vaes JEG, van Kammen CM, Trayford C, van der Toorn A, Ruhwedel T, Benders M, et al. Intranasal mesenchymal stem cell therapy to boost myelination after encephalopathy of prematurity. Glia. 2021;69(3):655\u201380. https:\/\/doi.org\/10.1002\/glia.23919.","journal-title":"Glia"},{"issue":"7","key":"4187_CR36","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jcyt.2017.03.075","volume":"19","author":"B Oppliger","year":"2017","unstructured":"Oppliger B, Joerger-Messerli MS, Simillion C, Mueller M, Surbek DV, Schoeberlein A. Mesenchymal stromal cells from umbilical cord Wharton\u2019s jelly trigger oligodendroglial differentiation in neural progenitor cells through cell-to-cell contact. Cytotherapy. 2017;19(7):829\u201338. https:\/\/doi.org\/10.1016\/j.jcyt.2017.03.075.","journal-title":"Cytotherapy"},{"issue":"6","key":"4187_CR37","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nn.3109","volume":"15","author":"L Bai","year":"2012","unstructured":"Bai L, Lennon DP, Caplan AI, DeChant A, Hecker J, Kranso J, et al. Hepatocyte growth factor mediates mesenchymal stem cell\u2013induced recovery in multiple sclerosis models. Nat Neurosci. 2012;15(6):862\u201370. https:\/\/doi.org\/10.1038\/nn.3109.","journal-title":"Nat Neurosci"},{"issue":"12","key":"4187_CR38","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1096\/fj.201700524R","volume":"31","author":"S Giacoppo","year":"2017","unstructured":"Giacoppo S, Thangavelu SR, Diomede F, Bramanti P, Conti P, Trubiani O, et al. Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37. Faseb j. 2017;31(12):5592\u2013608. https:\/\/doi.org\/10.1096\/fj.201700524R.","journal-title":"Faseb j"},{"issue":"10","key":"4187_CR39","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1002\/jcp.24981","volume":"230","author":"W Huang","year":"2015","unstructured":"Huang W, Lv B, Zeng H, Shi D, Liu Y, Chen F, et al. Paracrine factors secreted by MSCs promote astrocyte survival associated with GFAP downregulation after ischemic stroke via p38 MAPK and JNK. J Cell Physiol. 2015;230(10):2461\u201375. https:\/\/doi.org\/10.1002\/jcp.24981.","journal-title":"J Cell Physiol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04187-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04187-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04187-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T12:08:44Z","timestamp":1738930124000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04187-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4187"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04187-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5212510\/v1","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For animal experiments, (1) Title of the approved project: Therapeutic effect and mechanism of hUC-MSCs on a mouse model of NMOSD; (2) Name of the institutional approval committee or unit: Ethics committee of Shanghai Model Organisms; (3) Approval number: IACUC 2024-0021-1; (4) Date of approval: August, 2024. For human material, (1) Title of the approved project: Prospective multicenter randomized controlled trial of hUC-MSCs for the treatment of NMOSD; (2) Name of the institutional approval committee or unit: Ethics committee of Renji Hospital, Shanghai Jiaotong University School of Medicine; (3) Approval number: 2016-071k; (4) Date of approval: March, 2020. The patients and human donors provided written informed consent for participation in the study and the use of samples.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}